The pilot diagnostic test is Saliva Glucose. Diagnostic test portfolio includes Clinical Chemistry Tests (ie. Cholesterol).
This tumor marker test portfolio along with other tests was designed to help doctors diagnose cancer and plan treatment. Tumor markers can be used in guiding treatment decisions, monitoring treatment, predicting the chance of recovery, and predict or monitor for tumor recurrence.
The pilot diagnostic test will be allergens (peanut kernel) and the portfolio will consist of various communicable disease tests including Hepatitis A, B & C, HIV and TORCH.
The first test to be developed from a hormone category is Luteinizing Hormone (LH).
We are also exploring the application of the platform in Nucleic Acid analysis and its applications in personalized medicine.